Cell therapy goes through the approval road, and local innovation joins the ADC battle｜Annual
Time of Update: 2022-01-25
According to the statistics of R&D customers, including Pfizer, GlaxoSmithKline, Daiichi Sankyo, Roche and other multinational companies, a total of 10 ADC products have been deployed in the Chinese market, and 5 have entered the phase III clinical or NDA stage; local drugs in this field have been deployed.
[PNAS] Explore brain "events"-do you know what happens in the brain
Time of Update: 2021-12-07
Computational neuroscientists Maria Pope, Richard Betzel, and Olaf Sporns of Indiana University are using a new model of brain activity to explore an astonishing burst of activity in the human brain that has never been examined .
Cancer Commun: Paclitaxel Liposome + Cisplatin vs. Gemcitabine + Cisplatin First-line Therapeutic Efficacy of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Lung: A Multicenter
Time of Update: 2021-11-12
Studies have shown that for patients with locally advanced or metastatic LSCC, the PFS, OS, ORR and DCR of the LP regimen are similar to those of the GP regimen, but have more favorable toxicity .
How to carry out clinical trials of new 3 generic drugs
Time of Update: 2016-05-23
May 20 is the 11th international clinical trial day The results of clinical trials are the gold standard to judge the safety and effectiveness of a drug Since 2015, a series of CFDA's publications can